Zurueck zur Suche

Reporte zur Charge FA95N

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

31Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 6 WI 3 MD 2 FL 2 OK 1 ME 1 NY 1 ND 1 TX 1 IA 1 NM 1 PA 1

VAERS 2391183

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

schwer
Staat
OK
Alter
73,0
Geschlecht
M
Eingang
26.07.2022
Impfdatum
26.07.2022
Beginn
26.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Syncope

Symptomtext

Received call from pts. family reporting patient had a syncopal episode at home following vaccines and EMS had to be called.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2504575

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

moderat
Staat
ME
Alter
66,0
Geschlecht
M
Eingang
10.11.2022
Impfdatum
03.11.2022
Beginn
03.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Blood test Chest pain Electrocardiogram normal Injection site erythema Injection site pain Pain in extremity Pain in jaw Sleep disorder X-ray

Symptomtext

injection site was red and sore (minor), major problems extremely painful jaw on right side along with severe chest pain center chest. To a lesser degree arms and hands were aching from elbows to finger tips. I am able to monitor blood pressure and do at home EKG to monitor a fib and they reminded normal but pain was debilitating and would wake me from sleep. Episodes were sporadic and could last from 5 minutes to half an hour. Nothing seemed to relive pain. Doctor performed EKG, x ray, blood tests listened to heart and has ordered stress test. No cause has been determinded

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
x ray, blood tests, EKG, stress test ordered
Aktuelle Erkrankungen
n/a
Vorgeschichte
Sleep apnea, diabetes, low testosterone, a fib
Andere Medikamente
Protonix, Testim, Metoprolo, Nuetec, Metformin, Lantus, Flecainide, Eliguis, Emgality, Toprimate, Claritin, latanoprost
Allergien
Glipizide
Vorherige Impfungen
-

VAERS 2364295

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

moderat
Staat
NY
Alter
51,0
Geschlecht
F
Eingang
11.07.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Clumsiness Dizziness Fatigue Headache Injection site pain Musculoskeletal stiffness Myalgia Nausea Pain Pain in extremity Paraesthesia Rash erythematous Rash papular Rash vesicular Sleep disorder Tenderness Tendon pain

Symptomtext

Symptom Summary - (see "continuation page" for timeline & detail) o Significant pain in a corset-like ring around trunk of body - skin, muscles, seemingly internal organs ? both left and right sides (hrs. 12 ? 60 after vaccination) o raised rash & prickling in band on left side of trunk ? emerges aprox. 60 hrs. post vaccination o Rash develops blisters ? aprox. 72 hrs. post vaccination; blisters grow in size over next several days Accompanying the above - o fatigue o nausea o mild headache o dizziness/clumsiness o Muscle/tendon pain, skin sensitivity, tingling in left leg, knee, hand, arm, shoulder o No fever Additional information for Item 11: neurally mediated hypotension (similar to POTS, diagnosed by Dr. aprox. 1990) Symptom Timeline - Wednesday ? 6/29/22, Shingrix vaccination about 10 a.m. o Sore arm ? went for walk in evening; felt well, except for sore arm o By bedtime, pain in torso in a ring (corset area) around body o Skin - very tender, painful and raw, similar to a burn, but not red, inflamed, hot or swollen. o Muscle pain in the same area - soreness from ribs to lower abdomen and top of hips. o Nausea o tender stomach o Pain on sides, back, front ? mostly left and right of centerline on both front and back o Overnight - very painful to move, sit up, walk, lay down. Hard to find a position to sleep that was okay to allow sleep. Awakened by pain and nausea through the night and made it difficult to fall back asleep. o Mild headache o No fever Thursday - 6/30/22 o pain continues as above ? pain seems to be not only skin and muscles, but also internal organs. Abdominal pain and also higher by/under rib cage ? maybe where kidneys are ? really excruciating; mostly on left and right of center in back and front from rib cage to just below hip bones. o Now, intermittent dizziness and clumsiness. o Painful to walk. Painful to sit upright. o Hard to concentrate or think as clearly as usual. o Fatigued; small amounts of movement or sitting up are exhausting; must lay with legs elevated to recover. o Abdominal pain with some gas/flatulence. o Mild headache Friday ? 7/1/22 o Continuation of previous symptoms. o Muscle/internal pain seems to migrate down a bit. Less under rib cage, more in abdomen, but remains in both places. Pain in skin from hip bones down to legs (upper hip area); some pain/stiffness in muscles here, too. o Rash ? at bedtime, discover rash on left side of trunk, bumpy ? as though may form into blisters; rash is painful in a prickly way in addition to previous raw/burnt sensation. o Pain in left leg ? in evening, pain starts down left leg in skin of inner thigh and in connective tissue/muscles where leg meets groin. Saturday ? 7/2/22 o Continuation of previous symptoms. Overnight was not quite as bad. Pain subsiding in injection site, but persisting in trunk. o Pain in left leg ? o expands to skin and muscle along front of thigh above knee; knee is painful and somewhat swollen (more fluid in joint than right knee for comparison) o pain in leg keeping awake ? walked loops in house, because trunk/back pain while still present and worse with motion, was now not so bad as to prevent walking, fatigue had subsided and felt that movement & blood flow might help alleviate leg pain. o Rash ? expanding and more red/angry, feels more thick and stiff, rash is painful; appears to be forming small pin-prick size blisters. Sunday ? 7/3/22 o Injection site is only mild pain now, have full range of motion, pain if touch, but otherwise not bad. o Skin (aside from rash) pain in trunk ? not gone, but improving; skin painful above knee o Muscle pain ? improving; worst remaining muscle pain is in back on either side of spine. o Leg/knee ? pain continues above knee, in inner tendon along side of knee, behind knee o Rash ? expanding, red and filling in between bumps, blisters have emerged and enlarged, painful, thick, stiff o Abdominal pain is largely resolved except for some tenderness and slight nausea in center of lower abdomen. Gas/flatulence has resolved. o Fatigue ? improved, still need to rest after moving o Shooting pain in heal of left hand ? sudden onset while trying to fall asleep Sun. night o Start 7-day course of Valacylovir HCL, 1 g tab., 3x daily (every 8 hrs) for 7 days Monday ? 7/4/22 o Rash ? red, angry, large blisters o Mild nausea and lower abdominal tenderness continues o Fatigue ?near end of day, improved; able to move with less pain o Pain in hand/arm/shoulder ? o initial pain in heal of hand has expanded along skin towards pinky finger ? both surface and internal pain; skin hurts when touched; o pain runs from hand up arm (pain in hand, brachio radialis near elbow, deltoid, and trapezius) Tuesday ? 7/5/22 o Rash ? red, angry, stiff, blisters even larger o Pain continues in - o Leg/knee o Hand/arm/shoulder - (hand - pain/tingling in palm along MCV joints, down side below pinky to heal)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Note regarding item 21 - Patient had phone consultation and messaged with doctors through system, including images of rash. Drs.
Aktuelle Erkrankungen
neurally mediated hypotension (similar to POTS, diagnosed by Dr. aprox. 1990)
Vorgeschichte
Psoriasis, Psoriatic Arthritis, sub-clinical hypothyroidism, neurally mediated hypotension (similar to POTS)
Andere Medikamente
Taltz 80 mg/Kg, Levothyroxine 25 microg, fish oil, D3, B-12
Allergien
Sulfa, Methotrexate, Remicade, Enbrel, Cosentyx, Proamatine
Vorherige Impfungen
-

VAERS 2598672

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

mild
Staat
CA
Alter
58,0
Geschlecht
M
Eingang
17.03.2023
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Myalgia Pyrexia

Symptomtext

Patient experienced low grade fever along with muscle soreness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myalgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
None in pharmacy system
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 2525503

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

mild
Staat
ND
Alter
79,0
Geschlecht
F
Eingang
07.12.2022
Impfdatum
18.11.2022
Beginn
20.11.2022
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus Sleep disorder

Symptomtext

Patient states that a couple days after the shot she started experiencing severe itching. She doesn't have hives or a rash present, but itchiness is exacerbated by physically itching skin. Patient took Benadryl which seems to help. Her chief complaint is that the itching has kept her up at night and is quite bothersome. This problem did lead to her being seen in the clinic by a physician.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2478596

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge fa95n

mild
Staat
CA
Alter
51,0
Geschlecht
F
Eingang
14.10.2022
Impfdatum
11.10.2022
Beginn
14.10.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

Patient called us on 10/14/22 saying that she woke up this morning and found a large rash covering her chest, she is unsure how long that rash was there for. Patient denies difficulty breathing, swelling, itching, or pain. Advised patient to call and follow up with pcp.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
(from pt profile) dermatologic disorders, gerd, muscle spasm, pain/migraine, urinary retention, uti
Andere Medikamente
-
Allergien
(from pt profile) amoxicillin, penicillins
Vorherige Impfungen
-

VAERS 2472550

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

mild
Staat
TX
Alter
67,0
Geschlecht
F
Eingang
08.10.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Pain in extremity

Symptomtext

Site: Pain at Injection Site-Medium, Additional Details: Patient complaint that her left arm hurts but did not provide details

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2460520

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

mild
Staat
IA
Alter
67,0
Geschlecht
F
Eingang
26.09.2022
Impfdatum
09.09.2022
Beginn
15.09.2022
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pain Injection site rash

Symptomtext

Patient developed a rash on their left arm right around the site of administration. Rash developed about 5-6 days after receiving both injections. No itching was noticed by the patient but the soreness occurred for the next 3 days. Pateint received a 10 day course of Cephalexin in which she reported that it started to clear up by day 2. On completion of the 10 day course patient reported that the rash was fully cleared.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2425207

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge fa95n

mild
Staat
NM
Alter
53,0
Geschlecht
F
Eingang
31.08.2022
Impfdatum
30.08.2022
Beginn
30.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Insomnia Neck pain Pain Pain in extremity Sensitive skin

Symptomtext

L deltoid pain, radiating to hand and into L side of neck, unable to sleep due to pain, area very sensitive to touch

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
asthma, left shoulder pain
Vorgeschichte
asthma, type II DM
Andere Medikamente
acetominophen
Allergien
ibuprofen, metronidazole
Vorherige Impfungen
-

VAERS 2412875

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

mild
Staat
PA
Alter
66,0
Geschlecht
M
Eingang
16.08.2022
Impfdatum
16.08.2022
Beginn
16.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Discomfort Pyrexia

Symptomtext

Patient started experiencing shivering around 4 pm, a fever of 105 degrees farenheit at around 6 pm, and feeling of pressure going from his legs to the feet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
high blood pressure and cholesterol
Andere Medikamente
medication for high blood pressure and hypercholesteremia
Allergien
n/a
Vorherige Impfungen
-

VAERS 2412375

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

mild
Staat
NH
Alter
55,0
Geschlecht
F
Eingang
16.08.2022
Impfdatum
08.08.2022
Beginn
11.08.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Discomfort Fatigue Feeling abnormal Pruritus Pyrexia Rash

Symptomtext

Patient received Shingrix vaccine. 2-3 days later she developed a fever and a rash on her upper right thigh ankle and on left great toe. Reports this started 2 days after her shingles shot and has gotten worse. Reports fever fatigue and feeling really run down. Reports that it is mildly uncomfortable and consistent with a chicken pox dx her children had. Reports that she did have chicken pox as a child. Chicken pox- Keep area clean and dry, Tylenol for fever >100.3, Benadryl may help with the itch. Get plenty of rest Soothing lotion and moisturizers - Calamine solution can be applied on the rashes. Colloidal oatmeal also gives relief from itching. Patient advised to stay away from children and pregnant people. Advised if sx worsen she should contact the office for further eval and treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 2399461

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

mild
Staat
WI
Alter
65,0
Geschlecht
F
Eingang
02.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Headache Pyrexia Tinnitus

Symptomtext

Patient called pharmacy on 8/2/22 and spoke with me, (float pharmacist for Pharmacy). Patient indicated following recieving the Shingrix vaccine on 8/1/22, she started experiencing ringing in her ears. Review of the VIS indicated patient is to reach out to their healthcare provider if she experiences ringing in her ears. Upon further questioning, patient indicated the ringing had seemed to get worse 24 hours after receiving the vaccine. I provided the patient with the information for VAERS (both the website & the phone number) for patient to report on her own & indicated I would do so from my end as well. In addition, I advised patient to contact her doctor--and strongly advise she do so if the ringing in her ears persists/does not stop, does not improve, and/or worsens. Vaccine records indicate she had a previous dose of this vaccine on 10/15/21, making this her 2nd Shingrix vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Uknown. Patient has no recent history of any medications on file here at the Pharmacy.
Allergien
Documented allergies to Sulfa Drugs & Antibiotics, as well as Penicillins.
Vorherige Impfungen
-

VAERS 2728653

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
-
Alter
68,0
Geschlecht
F
Eingang
29.12.2023
Impfdatum
26.07.2022
Beginn
26.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Unevaluable event

Symptomtext

Vaccine Refridgerated

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2728636

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
-
Alter
63,0
Geschlecht
F
Eingang
29.12.2023
Impfdatum
15.07.2022
Beginn
15.07.2023
Tage bis Beginn
365,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2728236

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
-
Alter
70,0
Geschlecht
M
Eingang
28.12.2023
Impfdatum
21.07.2022
Beginn
21.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2728104

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
DC
Alter
52,0
Geschlecht
F
Eingang
28.12.2023
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2725425

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
MD
Alter
64,0
Geschlecht
F
Eingang
26.12.2023
Impfdatum
21.07.2022
Beginn
21.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2725425

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
MD
Alter
64,0
Geschlecht
F
Eingang
26.12.2023
Impfdatum
21.07.2022
Beginn
21.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
ID / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2731240

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
-
Alter
56,0
Geschlecht
F
Eingang
21.12.2023
Impfdatum
26.07.2022
Beginn
26.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2724455

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
-
Alter
55,0
Geschlecht
F
Eingang
15.12.2023
Impfdatum
22.07.2022
Beginn
22.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Vaccine was frozen instead of refrigerated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2723558

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
-
Alter
72,0
Geschlecht
M
Eingang
13.12.2023
Impfdatum
18.07.2022
Beginn
15.07.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2606986

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
CA
Alter
58,0
Geschlecht
M
Eingang
31.03.2023
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

3rd dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number FA95N, expiry date 28-JUL-2023) for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date in 2018) and Shingrix (2nd dose received on an unknown date in 2018). On 07-OCT-2022, the patient received the 3rd dose of Shingrix. On 07-OCT-2022, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: 3rd dose administered). The outcome of the extra dose administered was unknown. Additional Information: GSK Receipt Date: 17-MAR-2023 A pharmacist informed that a patient had received a 3rd dose of Shingrix, which led to extra dose administered. Originally the patient had finished the scheme back in 2018. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2511847

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
MN
Alter
75,0
Geschlecht
M
Eingang
18.11.2022
Impfdatum
05.08.2022
Beginn
15.11.2022
Tage bis Beginn
102,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Fall SARS-CoV-2 test positive

Symptomtext

Patient had dry cough and fall. Tested positive for Covid. Treatment includes assessment, medication, and admission.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Diabetes type 2
Andere Medikamente
-
Allergien
Statins-hmg-coa Reductace inhibitors
Vorherige Impfungen
-

VAERS 2500209

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
07.11.2022
Impfdatum
30.07.2022
Beginn
30.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

1st dose 21Dec2019, 2nd 30Jul2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) (batch number FA95N, expiry date 28th July 2023) for prophylaxis. Previously administered products included Shingrix (1st dose received on 21st December 2019). On 30th July 2022, the patient received the 2nd dose of Shingrix. On 30th July 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown. Additional Information: GSK Receipt Date: 28-OCT-2022 Reporter's comment: Pharmacist reported that a patient got first dose of Shingrix on 21st December 2019 and 2nd dose on 30th July 2022. The vaccine administration facility was the same as primary reporter. No information of the patient provided. The reporter consented to follow-up. Additional Supportive Information: The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccination schedule.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2498636

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
-
Alter
-
Geschlecht
M
Eingang
04.11.2022
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

two doses, one day apart; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number FA95N, expiry date unknown) for prophylaxis. Concurrent medical conditions included diabetes (Patient is diabetic). Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX). On 21st October 2022, the patient received the 2nd dose of Shingrix. On 21st October 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional Information: GSK Receipt Date: 25-OCT-2022 Reporter's Comment: The reporter called to ask for information about the administration of two doses of Shingrix to a patient one day apart. The reporter asked for safety information and how to proceed with patient vaccination. The reporter consented to follow up. Additional Supportive Information: The patient received the 2nd dose of Shingrix earlier than the recommended schedule, which led to drug dose administration interval too short.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Diabetes (Patient was diabetic)
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2494716

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
CA
Alter
86,0
Geschlecht
M
Eingang
31.10.2022
Impfdatum
29.10.2022
Beginn
29.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

The patient came in on 10/13/2022 for his first Shingles vaccine. He has no recollection that he came in this day for this shot. He remember inquiry about the shot but never got the shot. In reality, he filled out the immunization consent form and signed out as if he paid the zero copay at the register. The pharmacy manager double check the quantity of hand and everything is correct. It says 18 vaccines on hand and that is how many we have. If no shot have been given, there will be one extra shot on hand. The patient claims he has no adverse reaction when the pharmacy manager spoke to him. She advises that there needs to be a 2-6 months break between his 1st and 2nd shot so she advises him to come back in 2 to 6 months for the second shot to count toward the immunization schedule.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none known
Andere Medikamente
none on file
Allergien
none known
Vorherige Impfungen
-

VAERS 2494498

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
31.10.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product preparation issue

Symptomtext

Only adjuvant administered; Only adjuvant administered; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a patient who received Herpes zoster (Shingrix) (batch number FA95N, expiry date 28th July 2023) and (batch number 052JX, expiry date unknown) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered and inappropriate preparation of medication. On an unknown date, the outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown. Additional Information: GSK Receipt Date: 21-OCT-2022 Reporter's Comment: The reporter stated that a 2 antigen ( powder) was left in the Shingrix box and the reporter believes that 2 patient out of the 10 patients received only the adjuvant portion of the Shingrix. Hcp provided Lot number for both the powders that was left in the box: lot#FA95N, expiration date 28th July 2023 (Same lot# and expiration date for both powder). Liquid administered was lot number 052JX (same for both liquid no expiration available). The reporter was planning to revaccinate all 10 of them because she was unsure who got them. The reporter did not had any information to provide on the patients. The reporter give consent to follow up. This case is linked to the case US2022AMR153035, reported by the same reporter.; Sender's Comments: US-GSK-US2022AMR153035:Original Case : US2022152231

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2494484

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
31.10.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product preparation issue

Symptomtext

Only adjuvant administered; Only adjuvant administered; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number FA95N, expiry date 28th July 2023) and (batch number 052JX, expiry date unknown) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 21-OCT-2022 Reporter's Comment: The reporter stated that a 2 antigen (powder) was left in the shingrix box and the reporter believes that 2 patient out of the 10 patients received only the adjuvant portion of the shingrix. The reporter was planning to revaccinate all 10 of them because she was unsure who got them. The reporter did not had any information to provide on the patients. The Vaccine Administration Facility was the same as Primary Reporter The reporter give consent to follow up. This case was for 2 of 2 linked reports. Additional supportive information: The patient received only the adjuvant portion of the Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.; Sender's Comments: US-GSK-US2022152231:Same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2465175

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
30.09.2022
Impfdatum
-
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product preparation error

Symptomtext

powder reconstituted with another diluent; powder reconstituted with another diluent; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) (batch number 424JG, expiry date 28th July 2023) and (batch number FA95N, expiry date unknown) for prophylaxis. In August 2022, the patient received Shingrix. On an unknown date, the dose was an unknown dose. In August 2022, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 21-Sep-2022 Reporter's comment: The clinical coordinator called for enquiry. The reporter asked was there any safety information or any harm to patient. The reporter asked what should they do. The call center reported that they found 3 vials of Shingrix diluent and were doing an investigation, was unsure if three patients were given the powder reconstituted with another diluent. The call center was unsure and did not had a specific person/patient involved at that moment due to Healthcare professional investigating back from 15th August 2022 to 29th August 2022. The permission for consent to follow-up was denied. Additional Supportive Information: The patient was given the powder reconstituted with another diluent, which led to Wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. This case was linked with US2022135797 and US2022135798 reported by same reporter. Two different batch numbers were reported were 424JG and FA95N.; Sender's Comments: US-GSK-US2022135797:Same reporter US-GSK-US2022135798:Same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2417243

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
CA
Alter
63,0
Geschlecht
F
Eingang
22.08.2022
Impfdatum
20.07.2022
Beginn
04.08.2022
Tage bis Beginn
15,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Herpes zoster

Symptomtext

Patient reports that patient got shingles after receiving shingrix vaccine. she got the rx from ER for shingles on 08/04/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Herpes zoster
Hospital-Tage
-
Labordaten
not sure about medical testing but we receive the presription for valtrex 1gm from ER and patient states that she has shingles due to that vaccine
Aktuelle Erkrankungen
-
Vorgeschichte
arthritis, thyroid and fibromyalgia
Andere Medikamente
methotrexate 2.5mg tablet- 7t po q weekly trazodone 50mg- 1-2 tablet po q daily at night
Allergien
NKA
Vorherige Impfungen
-

VAERS 2373756

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FA95N

gering
Staat
FL
Alter
70,0
Geschlecht
F
Eingang
19.07.2022
Impfdatum
13.07.2022
Beginn
18.07.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Swelling

Symptomtext

Red and swollen in deltoid region

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure
Andere Medikamente
Metoprolol succinate
Allergien
None
Vorherige Impfungen
-